about
Unconventional myosin VIIA is a novel A-kinase-anchoring proteinOptimal timing and duration of induction therapy for HIV-1 infectionCharacterization of the motor activity of mammalian myosin VIIAInner ear and kidney anomalies caused by IAP insertion in an intron of the Eya1 gene in a mouse model of BOR syndromeThe effect of novel mutations on the structure and enzymatic activity of unconventional myosins associated with autosomal dominant non-syndromic hearing loss.Modelling the evolution and spread of HIV immune escape mutantsHIV evolutionary genetics.Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1On the origin and evolution of the human immunodeficiency virus (HIV).Population dynamics of HIV-1 inferred from gene sequences.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.The HIV Epidemic: High-Income Countries.Virus dynamics and drug therapyGenetic drift and within-host metapopulation dynamics of HIV-1 infectionStochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistanceEvolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection.Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor.The dynamics of HIV-1 adaptation in early infection.Drosophila myosin VIIA is a high duty ratio motor with a unique kinetic mechanism.Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.Heterozygous mutation of Ush1g/Sans in mice causes early-onset progressive hearing loss, which is recovered by reconstituting the strain-specific mutation in Cdh23.Effects of human deafness gamma-actin mutations (DFNA20/26) on actin function.Evolutionary trade-offs at two time-scales: competition versus persistence.Microbial genetics. The tinkerer's evolving tool-box.
P2860
Q28140474-6F8F1590-B898-4D9E-8A67-1B882CEA85F1Q28469250-72ED37F1-82D1-435D-AF37-081E394182E0Q28566322-4CEB6E6D-D8E7-4A9B-83C3-2E2564AE6647Q28593604-120AF743-7E99-4723-9FC1-F877A4D8F611Q30365318-F8745C2C-473C-4EC5-ADE1-99B25CBBCEE8Q30992754-1005BB0D-AE91-43C1-8CA4-4338D80203B9Q33732382-33A0D8D5-69C7-47A6-B2C0-351873530837Q33782562-44EC7477-5005-4CD8-9866-95D9D6DBEBA6Q33843999-B1528CC2-5745-434D-84B6-C9DA902ED98CQ33906239-6E99C67B-2F4C-4E58-A008-40E2476232E9Q33961507-D97F7392-7A1D-4F36-A154-3D7380997E65Q34092679-79B22900-D609-4457-9187-DBDCB19382BDQ34276664-03BFBE2E-8456-48B2-A9A4-609275EF7FBAQ34490344-DB2F7E76-3C7A-4CA8-ACEE-D4A9839A9E7FQ35742512-F2430A10-71B0-4561-A8D8-1B7C33BA9810Q35902684-D3D2FFBB-85AF-4954-AC08-99924C34DE1DQ36244920-87021FB9-49E7-4619-806B-7890356DDD6DQ36259922-9B240D39-08E9-4D21-A535-B7277114359DQ36735938-C90AE34D-F675-4390-A759-8FB5FCA22196Q36824026-4BEA999D-894D-482F-9FDD-FB24996CC316Q36954674-7E7BE38D-1F24-488C-AC02-D5A24B0E7915Q39577975-3E42592C-0BC6-4BD6-8148-78547E58F1B4Q39591902-A33C2A4D-EDB1-47BF-AB71-9A3ECE22B075Q42239239-AE0806C8-38A6-4C9B-B9C8-2E0A00E9C304Q42593675-1EC2104A-6128-4C0C-83F5-F097DA5FBCB1Q46895770-FCC09015-8B22-4C46-967D-B451494C11B6Q47917455-6939C54D-4D87-4B58-8AF1-8E34CA786A35Q50316944-FBAE63AB-B64E-4733-947B-81522CE6B62EQ50464854-9F5E3F62-09D1-4E9D-B005-468E028A9E58Q52080909-0302A8EB-7000-45D9-884E-E13B611436AFQ52262067-516A8941-EFDD-4FA6-9FBF-2468D01DA9FC
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
HIV-1: gambling on the evolution of drug resistance?
@en
type
label
HIV-1: gambling on the evolution of drug resistance?
@en
prefLabel
HIV-1: gambling on the evolution of drug resistance?
@en
P2860
P356
P1433
P1476
HIV-1: gambling on the evolution of drug resistance?
@en
P2093
P2860
P2888
P304
P356
10.1038/NM0397-268
P407
P577
1997-03-01T00:00:00Z